S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
NASDAQ:SIGY

Sigyn Therapeutics News Headlines

$0.68
0.00 (0.00%)
(As of 12/6/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.68
$0.68
50-Day Range
$0.46
$0.98
52-Week Range
$0.30
$3.50
Volume
N/A
Average Volume
2,252 shs
Market Capitalization
$25.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-1.11

Media Mentions By Week



Sigyn Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SIGY
News Sentiment

0.79

0.34

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SIGY Articles
This Week

1

0

SIGY Articles
Average Week

Get Sigyn Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SIGY and its competitors with MarketBeat's FREE daily newsletter.

Sigyn Therapeutics (NASDAQ:SIGY) News Headlines Today

SourceHeadline
finance.yahoo.com logoSigyn Therapeutics Reports the Successful Completion of a Study to Address Gram-Positive Bacterial Toxins Associated with Sepsis
finance.yahoo.com - December 1 at 9:17 AM
MarketBeat logoSigyn Therapeutics (NASDAQ:SIGY) vs. Inovio Pharmaceuticals (NASDAQ:INO) Head to Head Analysis
americanbankingnews.com - November 30 at 1:06 AM
MarketBeat logoComparing Sigyn Therapeutics (NASDAQ:SIGY) and SI-BONE (NASDAQ:SIBN)
americanbankingnews.com - November 19 at 11:32 AM
marketwatch.com logoQ4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies
marketwatch.com - November 17 at 8:23 AM
MarketBeat logoNephros (NASDAQ:NEPH) & Sigyn Therapeutics (NASDAQ:SIGY) Critical Review
americanbankingnews.com - November 14 at 9:06 PM
finanznachrichten.de logoThe Investor Summit: Sigyn Therapeutics, Inc. Announces Participation in the Q3 Virtual Investor Summit
finanznachrichten.de - August 18 at 9:03 PM
finance.yahoo.com logoSigyn Therapeutics, Inc. Announces Participation in the Q3 Virtual Investor Summit
finance.yahoo.com - August 16 at 4:14 PM
finance.yahoo.com logoSigyn Therapeutics CEO Note: A Treatment Candidate to Address Bloodstream Pathogens, Deadly Toxins and Inflammatory Disease Targets
finance.yahoo.com - August 10 at 8:40 AM
barrons.com logoSigyn Therapeutics Inc.
barrons.com - August 5 at 11:33 PM
Get Sigyn Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SIGY and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.